Fusion Pharmaceuticals Inc (FUSN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access FUSN Annual Balance Sheets →
From Fusion Pharmaceuticals Inc through Mar 31 2023, shifts in Mar 31 2024's assets and liabilities provide insight into the company's capital structure and financial stability.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2024)
(Dec 31 2023) (Sep 30 2023) (Jun 30 2023) (Mar 31 2023)
Assets
Cash & cash equivalent27.79
Short-term Investments, Total182.74
Cash & Short-term Investments209.00
Accounts receivable0.00
Other Current Assets0.47
Prepaid Expense And Other Assets Current9.92
Total Current Assets220.92
Equipment/Property/Plant Net6.58
Long-term investments72.59
Other Assets, Noncurrent21.00
Restricted Cash Current0.47
Deferred Income Tax Assets Net4.37
Restricted Cash Noncurrent0.85
Total Assets323.81
Liabilities
Accounts Payable, Current AC2.50
Accrued Liabilities And Other Liabilities13.63
Other Liabilities, Current0.00
Accrued Income Taxes, Current TA0.00
Deferred Revenue, Current DE0.33
Total Current Liabilities20.76
Long-term debt49.69
Total Long-term Debt49.69
Deferred Revenue, Noncurrent DE0.67
Other liabilities, Noncurrent10.87
Operating Lease Liability Current4.29
Income Taxes Payable Noncurrent0.30
Total Liabilities81.98
Stockholders' Equity
Additional Paid In Capital Common Stock652.84
Retained Earnings / Accumulated Deficit-410.43
Other Equity-0.58
Common Stockholder's Equity241.83
Total Stockholder's Equity241.83
Liabilities & Stockholder's Equity323.81
4 historic quarters locked

Sign in to unlock the full Fusion Pharmaceuticals Inc balance sheet history.

About Fusion Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-24-053958

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.